Cargando…
Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program
BACKGROUND: There are no approved medications for juvenile fibromyalgia (JFM), a disorder that is often under-diagnosed. The effects of milnacipran, a drug approved for the management of fibromyalgia (FM) in adults, was assessed in a clinical trial program for JFM. METHODS: Patients, ages 13–17 year...
Autores principales: | Arnold, Lesley M., Bateman, Lucinda, Palmer, Robert H., Lin, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480575/ https://www.ncbi.nlm.nih.gov/pubmed/26112278 http://dx.doi.org/10.1186/s12969-015-0025-9 |
Ejemplares similares
-
Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study
por: Bateman, Lucinda, et al.
Publicado: (2013) -
Effect of milnacipran on body weight in patients with fibromyalgia
por: Arnold, Lesley M, et al.
Publicado: (2012) -
Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010) -
Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial
por: Clauw, Daniel J, et al.
Publicado: (2013) -
Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Kranzler, Jay D, et al.
Publicado: (2010)